InvestorsHub Logo
Followers 87
Posts 6746
Boards Moderated 1
Alias Born 09/18/2009

Re: Preciouslife1 post# 40493

Wednesday, 09/06/2023 9:48:45 AM

Wednesday, September 06, 2023 9:48:45 AM

Post# of 43094
I listened to the video several times. Something about it is off, in my opinion. I think it comes down to the speaker's charity in regarding the Pfizer and Moderna products as "vaccines." There was no distinction between mRNA and traditional vaccines, which is understandable, since Novavax has to subsist from table scraps in the US market.

https://www.facebook.com/sandy.reece.52/posts/pfbid08YGqxeS71QNLr8j9QxoMBS9RzEnN82raY5NMkVuX2Dyo8VEPVGxwjrqqzZrVnrG3l

But, like Humanigen, acceptance of our products may have to be forced on the US market by the fact that the current standard of care isn't working, and could actually be doing more harm than good. I think this could become even clearer as we develop our lenz/vaccine/anti-viral cocktail, and actually produce the world's first true covid vaccine, when lenz is administered with the Novavax or Janssen vaccines.

Janssen gave up on the US market, leaving Nuvaxovid as the sole traditional vaccine in the US market. Novavax stock has consistently had the highest short interest fee in the US. And now, they are reporting healthy gains is share price.

https://www.highshortinterest.com/

"Novavax shares have risen over 20% since the beginning of this month, tied to rising hospitalization and death levels witnessed in August due to a new COVID-19 wave."

https://www.benzinga.com/news/23/09/34252396/why-novavax-stock-traded-higher-today

Also, management has previously advised us that an increase in ICU utilization could prompt a partner into including lenz in a large platform study. It may even make the FDA, or MHRA, give us an EUA or approval, based on a resubmission of our EUA application with additional safety and efficacy data included.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.